Angelman Syndrome Market to Witness Significant Growth Through 2034, Driven by Novel Therapeutic Advancements
According to DelveInsight’s estimates, the Angelman syndrome market size in the 7MM is expected to show positive growth…
YUTIQ Sees Continued Market Growth in Treatment of Chronic Non-Infectious Uveitis
YUTIQ addresses a significant unmet need in the treatment of chronic non-infectious uveitis affecting the posterior segment of…
Roche’s HEMLIBRA Achieves Significant Uptake Across Key Hemophilia A Markets
HEMLIBRA has strong market potential due to its unique, subcutaneous prophylactic treatment for Hemophilia A, including patients with…